U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies

MUMBAI, Feb 28 (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed.